The Dowlati research lab at Case Western Reserve University (CWRU) and University Hospitals Seidman Cancer Center is led by Dr. Afshin Dowlati, MD. His expertise lies in both the biology and clinical management of thoracic malignancies. He has led the thoracic program at CWRU since 2000. His research is focused on translational aspects of target validation and drug development. He is uniquely positioned to perform preclinical studies of novel drugs in cancer models with an eventual goal of taking them into the clinic. A major effort of the Dowlati research lab is to identify novel therapeutics for small cell lung cancer (SCLC). There has been little progress in the clinical management of this disease over the last three decades, due largely to limited knowledge about the underlying mechanisms driving this malignancy. We intend to use cell line and mouse models of SCLC to study the role of genomic mutations in SCLC and to generate preclinical data to support future clinical trial applications.
Company Details
- Employees
- 3
- Address
- Cleveland, Ohio, Us
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Keywords
- Small Cell Lung Cancer.
- HQ
- Cleveland, Ohio
Dowlati Lab Questions
Dowlati Lab's LinkedIn profile is https://www.linkedin.com/company/dowlatilab
Dowlati Lab has
3 employees.
View email and phone details for 3
employees at Dowlati Lab.
Dowlati Lab's industry is
Research Services
Dowlati Lab's top competitors are
The Metrohealth System (Cleveland, Oh),
Cleveland Alzheimer’s Disease Research Center,
Emmes,
Cwru Ems,
American Heart Association.
Dowlati Lab's categories are Research Services
